Among brokerages, CLSA has retained a Buy call on ITC while Citi has downgraded InterGlobe Aviation to Sell from Neutral. Here are the top brokerage calls for today:
CLSA on ITC | CLSA retains Buy call on ITC with a target price of Rs 235 per share. In its reverse-DCF analysis, CLSA sees implied revenue-ask at just 5% in the next 10 years versus 10% in the last decade and 15-20% expectation built in on other FMCG names.
Jefferies on IndusInd Bank | Jefferies believes that the bank's provisioning may be elevated in H2 as it covers for downgrades and some buffer provisions. The brokerage house maintains a Buy rating on IndusInd Bank with target at Rs 1,000 per share.
Citi on InterGlobe Aviation | Citi has downgraded IndiGo to Sell from Neutral saying that IndiGo’s market share might have peaked and it could trend lower as its peers ramp up. It revised the target price to Rs 1,400 per share from Rs 1,300 earlier.
Nomura on Dr Reddy’s Laboratories | The brokerage house notes the positive second interim results of Sputnik-V COVID-19 vaccine and that its efficacy appears to be better than other alternatives for India (large scale usage). Nomura maintains its Buy call on Dr Reddy's Labs.
Jefferies on Siemens | Jefferies has maintained an Underperform call on Siemens with a target price at Rs 900 per share.
CLSA on NBFCs | CLSA feels as growth picks up, drag of excess liquidity should ease and offset NIM pressure for NBFCs.